13.04.2013
- Even as U.S. officials this week awaited the arrival of a sample of the new bird flu virus from China - typically the first step in making a flu vaccine - government-backed...
12.04.2013
- Swiss drugmaker Roche has no plans to change its holding in Japan's Chugai Pharmaceutical and the recent weakening of the yen would not be a reason to trigger such a move. Asked if...
12.04.2013
- U.S. investment firm Royalty Pharma is considering sweetening its $6.6 billion offer for Irish drugmaker Elan by paying Elan shareholders more if the multiple sclerosis drug...
11.04.2013
- The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...
11.04.2013
- A spike in U.S. demand for flu drug Tamiflu and strong sales of mainstay cancer medicines lifted first-quarter sales at Roche by a bigger-than-expected 5%. The healthy performance...
11.04.2013
- Biotech firms eager to push drug candidates through clinical trials prompted an overall increase in R&D expenditure of 20% in just a year, research and consulting firm GlobalData...
10.04.2013
- GlaxoSmithKline, Britain's biggest drugmaker, is placing a small but important bet on a new way of treating diseases by targeting electrical signals in the body. The company said...
10.04.2013
- Thermo Fisher Scientific made a binding offer for Life Technologies on Tuesday as private equity firms raced to finalize a consortium to take the genetic testing equipment maker...
09.04.2013
- Sirion Biotech has won two additional private investors, one of them being Aumenta. Both contribute to a large extent to the current financing round side by side with the existing...
04.04.2013
- A number of U.S. farm groups want to extend a law that allows farmers to grow a genetically modified crop while regulatory approval of the variety is still being challenged in...
